Home/Filings/8-K/0000818479-26-000024
8-K//Current report

DENTSPLY SIRONA Inc. 8-K

Accession 0000818479-26-000024

$XRAYCIK 0000818479operating

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 7:55 AM ET

Size

786.0 KB

Accession

0000818479-26-000024

Research Summary

AI-generated summary of this filing

Updated

DENTSPLY SIRONA Inc. Appoints New Board Director Donald Zurbay

What Happened

  • DENTSPLY SIRONA Inc. announced on Jan. 10, 2026 (8-K filed Jan. 13, 2026) that its Board approved increasing the number of directors from 10 to 11 and appointed Donald J. Zurbay as a director, effective immediately.
  • Mr. Zurbay will serve until the Company’s 2026 annual meeting of stockholders and has been named a member of the Board’s Audit and Finance Committee.
  • The company disclosed that Mr. Zurbay has no family ties to current executives or directors, no reportable related-party interests under Item 404(a) of Regulation S‑K, and will receive the same compensation as other non-employee directors (as described in the Company’s April 9, 2025 proxy).

Key Details

  • Effective date of appointment: January 10, 2026 (8-K filed January 13, 2026).
  • Board size change: increased from 10 to 11 directors.
  • Committee assignment: Audit and Finance Committee member.
  • Compensation: will participate in the same non-employee director compensation plans disclosed in the Company’s 2025 proxy statement.

Why It Matters

  • Board composition and committee membership affect corporate governance and oversight; adding a director to the Audit and Finance Committee can strengthen financial oversight.
  • The appointment is routine and non-controversial: no related-party transactions were disclosed and Mr. Zurbay will receive standard non-employee director pay.
  • For investors, this is primarily a governance update (filed on Form 8-K); there are no reported changes to executive management or direct financial impacts disclosed in this filing.